Schedule 13D ownership disclosure
MIRAGEN THERAPEUTICS, INC.
Security class unavailable · CUSIP: 60463E103
Event date: 2017-02-13
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,607,437
- Percent of class
- Unavailable
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001596770-17-000004
- Form type
- SC 13D
- Filer
- Boulder Ventures V, L.P.
- CIK
- CIK 1554282
- Filed
- Feb 24, 2017
- Reporting period
- Feb 13, 2017
- Description
- Schedule 13D beneficial ownership